Teva Pharmaceuticals will close its Fairfield, New Jersey manufacturing facility by February 1, 2027. This closure will result in the layoff of 61 employees. The company cited the plant's underutilization and high operating costs as reasons for the decision. Declining demand and price erosion also contributed to the plant's economic challenges. Teva plans to reallocate resources to higher-priority investment opportunities.
Fairfield, New Jersey
https://www.fiercepharma.com/pharma/teva-telegraphs-61-job-cuts-amid-plans-close-underutilized-new-jersey-plant